Annual Cash & Cash Equivalents
$36.02 M
+$6.50 M+22.01%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual cash & cash equivalents is currently $36.02 million, with the most recent change of +$6.50 million (+22.01%) on 31 December 2023. During the last 3 years, it has risen by +$34.43 million (+2175.11%). ACRV annual cash & cash equivalents is now -63.84% below its all-time high of $99.60 million, reached on 31 December 2021.ACRV Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$43.41 M
-$2.59 M-5.63%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly cash and cash equivalents is currently $43.41 million, with the most recent change of -$2.59 million (-5.63%) on 30 September 2024. Over the past year, it has increased by +$13.56 million (+45.40%). ACRV quarterly cash and cash equivalents is now -56.41% below its all-time high of $99.60 million, reached on 01 December 2021.ACRV Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.0% | +45.4% |
| 3 y3 years | +2175.1% | -56.4% |
| 5 y5 years | - | - |
ACRV Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -63.8% | +2175.1% | -56.4% | +76.4% |
| 5 y | 5 years | -63.8% | +2175.1% | -56.4% | +76.4% |
| alltime | all time | -63.8% | +2175.1% | -56.4% | +76.4% |
Acrivon Therapeutics Common Stock Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $43.41 M(-5.6%) |
| June 2024 | - | $46.01 M(+87.0%) |
| Mar 2024 | - | $24.61 M(-31.7%) |
| Dec 2023 | $36.02 M | $36.02 M(+20.6%) |
| Sept 2023 | - | $29.86 M(-21.6%) |
| June 2023 | - | $38.07 M(+38.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $27.49 M(-6.9%) |
| Dec 2022 | $29.52 M(-70.4%) | $29.52 M(-8.0%) |
| Sept 2022 | - | $32.08 M(-61.7%) |
| June 2022 | - | $83.86 M(-15.8%) |
| Dec 2021 | $99.60 M(+6192.0%) | - |
| Dec 2021 | - | $99.60 M |
| Dec 2020 | $1.58 M | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual cash & cash equivalents year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly cash and cash equivalents year-on-year change?
What is Acrivon Therapeutics Common Stock annual cash & cash equivalents?
The current annual cash & cash equivalents of ACRV is $36.02 M
What is the all time high annual cash & cash equivalents for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual cash & cash equivalents is $99.60 M
What is Acrivon Therapeutics Common Stock annual cash & cash equivalents year-on-year change?
Over the past year, ACRV annual cash & cash equivalents has changed by +$6.50 M (+22.01%)
What is Acrivon Therapeutics Common Stock quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ACRV is $43.41 M
What is the all time high quarterly cash and cash equivalents for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly cash and cash equivalents is $99.60 M
What is Acrivon Therapeutics Common Stock quarterly cash and cash equivalents year-on-year change?
Over the past year, ACRV quarterly cash and cash equivalents has changed by +$13.56 M (+45.40%)